The ratio of progerin to mature lamin A correlates with disease severity in HGPS patients, and can be used to assess the effectiveness of therapies aimed at lessening aberrant splicing or progerin farnesylation. This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.